clinical trial · NCT03809429
Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)
Infertility, FemaleFE 999049 + GnRH agonist (GONAPEPTYL)FE 999049 + GnRH antagonist (CETROTIDE)
brief summary
To compare the efficacy and safety of FE 999049 (follitropin delta) and its personalized dosing algorithm in controlled ovarian stimulation for in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) using a long gonadotropin-releasing hormone (GnRH) agonist protocol versus a short GnRH antagonist protocol.
started
Apr 29, 2019
primary completion
Feb 16, 2022
completion
Feb 16, 2022
last updated
May 13, 2024
official title
A Randomised, Controlled, Open Label, Parallel Group, Multicentre Trial Comparing the Efficacy and Safety of Individualised FE 999049 (Follitropin Delta) Dosing, Using a Long GnRH Agonist Protocol and a GnRH Antagonist Protocol in Women Undergoing Controlled Ovarian Stimulation
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol